Clinical Trials Browser

Phase 1/2 × Arginine × Clear all

NCT07150806 2025-12-22

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Phase 1/2 Recruiting

Meningioma

NCT02844387 2016-07-28

Supplementation of L-arginine in Patients With Non-resectable Brain Metastases

Phase 1/2 Completed

Neoplasms